Literature DB >> 18750480

Exogenous surfactant for the respiratory distress syndrome.

T A Merritt, M Hallman.   

Abstract

Entities:  

Year:  1988        PMID： 18750480      PMCID： PMC1026498     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  5 in total

1.  Artificial surfactant therapy in hyaline-membrane disease.

Authors:  T Fujiwara; H Maeta; S Chida; T Morita; Y Watabe; T Abe
Journal:  Lancet       Date:  1980-01-12       Impact factor: 79.321

2.  Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity.

Authors:  S D Revak; T A Merritt; E Degryse; L Stefani; M Courtney; M Hallman; C G Cochrane
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

3.  Prophylactic treatment of very premature infants with human surfactant.

Authors:  T A Merritt; M Hallman; B T Bloom; C Berry; K Benirschke; D Sahn; T Key; D Edwards; A L Jarvenpaa; M Pohjavuori
Journal:  N Engl J Med       Date:  1986-09-25       Impact factor: 91.245

4.  Respiratory distress syndrome treated with human surfactant: radiographic findings.

Authors:  D K Edwards; S V Hilton; T A Merritt; M Hallman; F Mannino; B R Boynton
Journal:  Radiology       Date:  1985-11       Impact factor: 11.105

5.  Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial.

Authors:  M Hallman; T A Merritt; A L Jarvenpaa; B Boynton; F Mannino; L Gluck; T Moore; D Edwards
Journal:  J Pediatr       Date:  1985-06       Impact factor: 4.406
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.